Yunnan Botanee Bio-Technology Group Co Ltd
SZSE:300957
Intrinsic Value
Yunnan Botanee Bio-Technology Group Co., Ltd. engages in the research and development, manufacture, and sales of skin care products and services. [ Read More ]
The intrinsic value of one
Yunnan Botanee Bio-Technology Group Co Ltd
stock under the Base Case scenario is
83.22
CNY.
Compared to the current market price of 57.16 CNY,
Yunnan Botanee Bio-Technology Group Co Ltd
is
Undervalued by 31%.
Yunnan Botanee Bio-Technology Group Co Ltd's market capitalization is 24.2B CNY.
Yunnan Botanee Bio-Technology Group Co Ltd stock price is 57.16 CNY.
Yunnan Botanee Bio-Technology Group Co Ltd stock price (57.16 CNY) is 31% less than its Intrinsic Value (83.22 CNY).
Yunnan Botanee Bio-Technology Group Co Ltd stock price (57.16 CNY) is 27% less than its DCF Value (78.79 CNY). Open DCF Valuation
Yunnan Botanee Bio-Technology Group Co Ltd stock price (57.16 CNY) is 35% less than its Relative Value (87.65 CNY). Open Relative Valuation
Yunnan Botanee Bio-Technology Group Co Ltd has upside potential of 53% compared to the average analyst price target.
Open Wall St Estimates
Yunnan Botanee Bio-Technology Group Co Ltd's Revenue has grown by 16% over the past 12 months.
Yunnan Botanee Bio-Technology Group Co Ltd's ROE (Return on Equity) has increased in the last 3 years from 15% to 21%.
Yunnan Botanee Bio-Technology Group Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 21%.
Yunnan Botanee Bio-Technology Group Co Ltd has positive Net Income for the last twelve months.
Yunnan Botanee Bio-Technology Group Co Ltd has positive Operating Income for the last twelve months.
Yunnan Botanee Bio-Technology Group Co Ltd's Revenue is forecast to grow at a rate of 23% per year over the next 3 years.
Yunnan Botanee Bio-Technology Group Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is very high and is equal to 35%.
Yunnan Botanee Bio-Technology Group Co Ltd's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 86% to 35%.
Yunnan Botanee Bio-Technology Group Co Ltd has positive Free Cash Flow for the last twelve months.
Yunnan Botanee Bio-Technology Group Co Ltd has positive three-year average ROE (Return on Equity): 24%. The company is efficient at transforming stockholders' equity into net income.
Yunnan Botanee Bio-Technology Group Co Ltd has positive Gross Profit for the last twelve months.
Yunnan Botanee Bio-Technology Group Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.02.
Yunnan Botanee Bio-Technology Group Co Ltd has very high three-year average ROIC (Return on Invested Capital): 60%. The company is very efficient at using invested capital to generate operating income.
Yunnan Botanee Bio-Technology Group Co Ltd's short-term assets (5B CNY) exceed its short-term liabilties (719m CNY).
Yunnan Botanee Bio-Technology Group Co Ltd's long-term assets (7B CNY) exceed its long-term liabilties (974m CNY).
Yunnan Botanee Bio-Technology Group Co Ltd has negative Net Debt. This means that the company has more cash and short-term investments (4B CNY) than debt (86m CNY).
Yunnan Botanee Bio-Technology Group Co Ltd's Altman Z-Score is very high and is equal to 26.51.
Valuation Backtest
Yunnan Botanee Bio-Technology Group Co Ltd
Run backtest to discover the historical profit from buying and selling
Yunnan Botanee Bio-Technology Group Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Yunnan Botanee Bio-Technology Group Co Ltd
Balance Sheet Decomposition
Yunnan Botanee Bio-Technology Group Co Ltd
| Current Assets | 5.5B |
| Cash & Short-Term Investments | 3.5B |
| Receivables | 1.2B |
| Other Current Assets | 769.3m |
| Non-Current Assets | 1.2B |
| Long-Term Investments | 132m |
| PP&E | 780.4m |
| Intangibles | 89.2m |
| Other Non-Current Assets | 170.3m |
| Current Liabilities | 718.5m |
| Accounts Payable | 210.4m |
| Accrued Liabilities | 141.1m |
| Short-Term Debt | 19m |
| Other Current Liabilities | 348.1m |
| Non-Current Liabilities | 255.5m |
| Long-Term Debt | 66.9m |
| Other Non-Current Liabilities | 188.6m |
Earnings Waterfall
Yunnan Botanee Bio-Technology Group Co Ltd
|
Revenue
|
5.5B
CNY
|
|
Cost of Revenue
|
-1.4B
CNY
|
|
Gross Profit
|
4.1B
CNY
|
|
Operating Expenses
|
-2.9B
CNY
|
|
Operating Income
|
1.2B
CNY
|
|
Other Expenses
|
-78.4m
CNY
|
|
Net Income
|
1.1B
CNY
|
Free Cash Flow Analysis
Yunnan Botanee Bio-Technology Group Co Ltd
Profitability Score
Profitability Due Diligence
Yunnan Botanee Bio-Technology Group Co Ltd's profitability score is 71/100. The higher the profitability score, the more profitable the company is.
Score
Yunnan Botanee Bio-Technology Group Co Ltd's profitability score is 71/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Yunnan Botanee Bio-Technology Group Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Yunnan Botanee Bio-Technology Group Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Yunnan Botanee Bio-Technology Group Co Ltd
According to Wall Street analysts, the average 1-year price target for
Yunnan Botanee Bio-Technology Group Co Ltd
is 87.49 CNY
with a low forecast of 60.6 CNY and a high forecast of 131.25 CNY.
Shareholder Return
Price
Yunnan Botanee Bio-Technology Group Co Ltd
| Average Annual Return | -2.92% |
| Standard Deviation of Annual Returns | 27.83% |
| Max Drawdown | -81% |
| Market Capitalization | 24.2B CNY |
| Shares Outstanding | 423 600 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Yunnan Botanee Bio-Technology Group Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Yunnan Botanee Bio-Technology Group Co., Ltd. engages in the research and development, manufacture, and sales of skin care products and services. The company is headquartered in Kunming, Yunnan and currently employs 2,378 full-time employees. The company went IPO on 2021-03-25. The firm adopts a sales model based on offline channel sales and online channel sales as the leading factor. The firm's products mainly include creams, skin care lotions, facial masks, essences, lotions and other skin care products and make-up products such as isolation creams, blemish balm (BB) creams, and makeup removers. The firm is also engaged in the research and development, production and sales of skin care-related medical device products, mainly including hyaluronic acid repairing biofilm, hyaluronic acid repairing dressings, mainly used for the protection of skin with damaged barriers after minimally invasive surgery and care.
Contact
IPO
Employees
Officers
The intrinsic value of one
Yunnan Botanee Bio-Technology Group Co Ltd
stock under the Base Case scenario is
83.22
CNY.
Compared to the current market price of 57.16 CNY,
Yunnan Botanee Bio-Technology Group Co Ltd
is
Undervalued by 31%.
You don't have any saved screeners yet
